Product
Systemic Therapy
Aliases
systemic therapy, Systemic therapy
Name
systemic therapy
5 clinical trials
10 indications
Indication
Prostate CancerIndication
Oligometastatic DiseaseIndication
Gallbladder CancerIndication
Esophageal squamous cell carcinomaIndication
RadiotherapyIndication
Metastatic Solid TumorsIndication
Triple-Negative Breast CancerIndication
Lung CancerIndication
Breast CancerIndication
Metastatic Non-Small Cell Lung CarcinomaClinical trial
Phase 2 Randomized Total Eradication of Metastatic Lesions Following Definitive Radiation to the Prostate in de Novo oligometaStatic Prostate Cancer (TERPS) TrialStatus: Recruiting, Estimated PCD: 2026-07-31
Clinical trial
Systemic Therapy With or Without Radiation Therapy in Unresectable Nonmetastatic Gall Bladder Carcinoma: Open Label, Parallel Arm, Phase 2/3 Integrated Randomized Clinical TrialStatus: Recruiting, Estimated PCD: 2029-07-21
Clinical trial
Phase III Randomized-controlled Study of PD-1 Inhibitor Combined With Local Therapy in Patients With Oligometastatic Esophageal Squamous Cell CarcinomaStatus: Recruiting, Estimated PCD: 2025-09-27
Clinical trial
A Randomized Trial of Early, Upfront Palliative Radiation Therapy Versus Standard of Care for Patients With Highest Risk Asymptomatic or Minimally Symptomatic Bone MetastasesStatus: Completed, Estimated PCD: 2024-04-18
Clinical trial
PROMISE-005: A Phase II Randomized Study Assessing the Efficacy of Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Breast or Lung CancerStatus: Recruiting, Estimated PCD: 2025-01-01